AU6110700A - Drug target isogenes: polymorphisms in the dopamine receptor d2 gene - Google Patents

Drug target isogenes: polymorphisms in the dopamine receptor d2 gene

Info

Publication number
AU6110700A
AU6110700A AU61107/00A AU6110700A AU6110700A AU 6110700 A AU6110700 A AU 6110700A AU 61107/00 A AU61107/00 A AU 61107/00A AU 6110700 A AU6110700 A AU 6110700A AU 6110700 A AU6110700 A AU 6110700A
Authority
AU
Australia
Prior art keywords
polymorphisms
gene
dopamine receptor
drug target
isogenes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61107/00A
Inventor
Anne Chew
R. Rex Denton
Amy Duda
Krishnan Nandabalan
Joel Claiborne Stephens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Publication of AU6110700A publication Critical patent/AU6110700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU61107/00A 1999-07-19 2000-07-19 Drug target isogenes: polymorphisms in the dopamine receptor d2 gene Abandoned AU6110700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14449399P 1999-07-19 1999-07-19
US60144493 1999-07-19
PCT/US2000/019644 WO2001005832A1 (en) 1999-07-19 2000-07-19 Drug target isogenes: polymorphisms in the dopamine receptor d2 gene

Publications (1)

Publication Number Publication Date
AU6110700A true AU6110700A (en) 2001-02-05

Family

ID=22508851

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61107/00A Abandoned AU6110700A (en) 1999-07-19 2000-07-19 Drug target isogenes: polymorphisms in the dopamine receptor d2 gene

Country Status (2)

Country Link
AU (1) AU6110700A (en)
WO (1) WO2001005832A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176303B2 (en) * 2003-11-06 2007-02-13 Isis Pharmaceuticals, Inc. Modulation of STAT5 expression
US20090291432A1 (en) * 2004-06-01 2009-11-26 Queensland University Of Technology Genetic profiles associated with the 957C>T polymorphism in the DRD2 gene
WO2006032436A2 (en) 2004-09-21 2006-03-30 Nascacell Technologies Ag. Use of microproteins as tryptase inhibitors
US20090075827A1 (en) * 2007-01-19 2009-03-19 Queensland University Of Technology Diagnostic methods and agents
US20140378351A1 (en) * 2013-06-22 2014-12-25 Brian Meshkin System and method for processing genotype information relating to treatment with pain medication

Also Published As

Publication number Publication date
WO2001005832A1 (en) 2001-01-25

Similar Documents

Publication Publication Date Title
AU2123200A (en) Drug delivery device
AU4985600A (en) Drug delivery device
AU4947100A (en) Drug delivery device
AU3178200A (en) Genetic analysis
AU1922801A (en) Genomic polymorphism for predicting therapeutic response
AU6492400A (en) Drug target isogenes: polymorphisms in the prostaglandin-endoperoxide synthase 2gene
AU1738601A (en) Swellable delivery system
AU6110700A (en) Drug target isogenes: polymorphisms in the dopamine receptor d2 gene
AU2000263446A1 (en) Drug target isogenes: polymorphisms in the interleukin 4 receptor alpha gene
AU7388700A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene
AU2258601A (en) Ibd-related polymorphisms
AU6755300A (en) Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene
AU1081401A (en) Drug target isogenes: polymorphisms in the m1 muscarinic acetylcholine receptor gene
AU6343400A (en) Drug target isogenes: polymorphisms in the osteoclastogenesis inhibitory factor gene
AU5016200A (en) Diabetes gene
AU2001213316A8 (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene
AU1773501A (en) Human single nucleotide polymorphisms
AU2000236029A1 (en) Receptor isogenes: polymorphisms in the tissue necrosis factor receptor
AU7994500A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1b gene
AU1570701A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1e gene
AU2001213316A1 (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene
AU4808200A (en) Dna balls
AU6871900A (en) Tsg-like gene
AU1870000A (en) Gene therapy-2
AU1338901A (en) Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 5 gene

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase